Traded Jul 22 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Loading…
Traded Jun 22, 2026 · Filed Jun 24, 2026
The CFO of United Therapeutics sold $677K of United Therapeutics shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$676,563
Shares × reported transaction price
47 days after results of May 6, 2026, 44 days before results of Aug 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −0.5% | +1.7% | −2.2% |
| 30 days | −3.9% | +0.8% | −4.7% |
| 90 days | −9.5% | +5.5% | −15.0% |
Past results only. Not a forecast.
Traded Jul 22 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Traded Jul 22 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Traded Jul 22 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.